Picato gel contains the active ingredient ingenol mebutate, which is a compound purified from the Euphorbia peplus plant. It is used to treat a skin condition called actinic keratosis. The global Picato Gel (Ingenol Mebutate) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Picato Gel (Ingenol Mebutate) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Picato Gel (Ingenol Mebutate) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Picato Gel (Ingenol Mebutate) in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Picato Gel (Ingenol Mebutate) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. The following manufacturers are covered: Leo Pharma ... Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type Type I Type II Segment by Application Actinic Keratosis Keratosis
Table of Contents Executive Summary 1 Industry Overview of Picato Gel (Ingenol Mebutate) 1.1 Definition of Picato Gel (Ingenol Mebutate) 1.2 Picato Gel (Ingenol Mebutate) Segment by Type 1.2.1 Global Picato Gel (Ingenol Mebutate) Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Type I 1.2.3 Type II 1.3 Picato Gel (Ingenol Mebutate) Segment